m+Medelevator.RU
← Поиск публикаций
Fertility and sterility · 2005

Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.

Клиническое исследованиеСравнительное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Prakash Alka, Laird Susan, Tuckerman Elizabeth, Li Tin C, Ledger William L

Аннотация

OBJECTIVE: To look at the role of inhibin and activin in predicting pregnancy outcome in patients with history of recurrent miscarriage.

DESIGN: Observational clinical study.

SETTING: Recurrent miscarriage clinic of a tertiary care teaching hospital.

PATIENT(S): Patients with history of recurrent miscarriage.

INTERVENTION(S): Serial serum inhibin A and activin A concentrations were measured in weeks 5 though 8 of pregnancy.

MAIN OUTCOME MEASURE(S): Serum concentrations of inhibin A and activin A levels.

RESULT(S): Mean inhibin A concentration at 5 to 6 weeks for women who miscarried and those who had live births was 33 and 51 pg/mL, respectively; activin A at same gestation for the two groups was 534 and 643 pg/mL, respectively. After 2 weeks, mean inhibin A concentration for women who miscarried and those who had live births was 66 and 145 pg/mL, respectively, and activin A was 747 and 1,123 pg/mL, respectively.

CONCLUSION(S): It is possible that inhibin A and activin A may be used as markers to predict pregnancies that are likely to miscarry.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты